Background Image
Table of Contents Table of Contents
Previous Page  47 / 60 Next Page
Information
Show Menu
Previous Page 47 / 60 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 32, No 1, January/February 2021

AFRICA

45

Burden of Disease Study.

Int Health

2020: 1–9.

8.

Institute for Health Metrics and Evaluation (IHME). Country Profiles.

Ethiopia.

[Online] 2020.

http://www.healthdata.org/ethiopia.

9.

Institute for Health Metrics and Evaluation. GHDx. Global Health Data

Exchange.

[Online] 2017.

http://ghdx.healthdata.org/gbd-results-tool.

10. World Health Organization. CVD World Monitor

.

[Online] 2012. http://

cvdworldmonitor.org/targets/premature-mortality-due-to-cvd/.

11. Yadeta D, Hailu A, Haileamlak A,

et al

. Prevalence of rheumatic heart

disease among school children in Ethiopia: A multisite echocardiogra-

phy-based screening.

Int J Cardiol

2016;

221

: 260–263.

12. Gemechu T, Mahmoud H, Parry EH,

et al

. Community-based preva-

lence study of rheumatic heart disease in rural Ethiopia.

Eur J Prev

Cardiol

2017;

24

(7): 717–723.

13. Ethiopian Public Health Institute. Ethiopia STEPS Survey 2015, Fact

Sheet. [Online] 2015.

http://www.ephi.gov.et/.

14. Rudatsikira E, Abdo A, Muula AS. Prevalence and determinants of

adolescent tobacco smoking in Addis Ababa, Ethiopia.

BMC Public

Health

2007;

7

: 176.

15. World Health Organization. Global Report on Mortality Attributable

to Tobacco

.

Geneva, Switzerland: World Health Organization, 2012.

16. Gebreyes YF, Goshu DY, Geletew TK,

et al.

Prevalence of high blood

pressure, hyperglycemia, dyslipidemia, metabolic syndrome and their

determinants in Ethiopia: Evidences from the National NCDs STEPS

Survey, 2015.

PLoS ONE

2018;

13

(5): e0194819.

17. The Federal Ministry of Health. Ethiopia STEPS Report on risk factors

for chronic non-communicable diseases and prevalence of selected

NCDs.

Addis Ababa, Ethiopia: Ethiopian Public Health Institute,

December 2016.

18. International Diabetes Federation (IDF).

IDF Diabetes Atlas.

9th edn.

[Online] 2019.

http://www.diabetesatlas.org/en/resources/.html.

19. World Health Organization. The World Health Organization

(WHO) framework convention on tobacco control (FCTC). [Online]

2016.

https://untobaccocontrol.org/impldb/wp-content/uploads/

Ethiopia_2016_report.pdf.

20. Zühlke L, Engel ME, Karthikeyan G,

et al.

Characteristics, complica-

tions, and gaps in evidence-based interventions in rheumatic heart

disease: The Global Rheumatic Heart Disease Registry (the REMEDY

study).

Eur Heart J

2015;

36

: 1115–1122.

21. Valluri S, Gaziano TA. Progress in national and regional guidelines

development and deployment for the clinical prevention and control of

CVD and diabetes in Africa.

Prog Cardiovasc Dis

2013;

56

(3): 336–343.

22. The Federal Ministry of Health. Guidelines on Clinical and

Programmatic Management of Major Non Communicable Diseases.

Addis Ababa, Ethiopia: Federal Democratic Republic of Ethiopia

Ministry of Health, 2016.

23. Ministry of Health Ethiopia. Essential Health Services Package of

Ethiopia. Addis Ababa: MoH, November 2019.

24. Shiferaw F, Letebo M, Misganaw A,

et al

. Non-communicable diseases

in Ethiopia: Disease burden, gaps in health care delivery and strategic

directions.

Ethiop J Health Dev

2018;

32

(3): 1–12.

25. The Federal Ministry of Health. Ethiopia Service Availability and

Readiness Assessment (SARA) 2018 Final Report.

Addis Ababa,

Ethiopia: Ethiopian Public Health Institute, May, 2018.

26. Food, Medicine and Healthcare Administration and Control authority

of Ethiopia.

National Essential Medicine List.

5th edn. Addis Ababa:

EFMHACA, January, 2015.

27. Ministry of Health.

National Training on Rheumatic Heart Disease

Prevention & Control for Health Care Workers in Ethiopia: Participant’s

Manual.

Addis Ababa: Federal Democratic Republic of Ethiopia,

September 2017.

28. Ali EE. Health care financing in Ethiopia: Implications on access to

essential medicines.

Value Health Reg Issues

2014;

4

: 37–40.

29. Bonsa F, Gudina EK, Hajito KW. Prevalence of hypertension and asso-

ciated factors in Bedele Town, southwest Ethiopia.

Ethiop J Health Sci

2014;

24

(1): 21–26.

30. Yadeta D, Semeredin N, Mekonnen GE. Prevalence and predictors of

atrial fibrillation and its embolic complications in patients with rheu-

matic heart disease at Tikur Anbessa specialized hospital, Addis Ababa,

Ethiopia.

Ethiop J Health Dev

2019;

33

(1): 12–16.

31. Endewunet E, Tadesse A, Adane A,

et al.

Appropriate use of anti-

thrombotic therapy in patients with atrial fibrillation at single center

experience, Northwest Ethiopia.

BMC Cardiovasc Disord

2020;

20

: 375.

32. Tegene E, Tadesse I, Markos Y,

et al

. Prevalence and risk factors for

atrial fibrillation and its anticoagulant requirement in adults aged ≥ 40 in

Jimma Town, southwest Ethiopia: A community based cross-sectional

study.

IJC Heart Vasc

2019;

22

: 199–204.

33. The Federal Ministry of Health.

Health Sector Development Program

IV

(ggggggggggggggggHSDP IV) 2010/11–2014/15

.

Addis Ababa,

Ethiopia: Federal Democratic of Ethiopia, Minister of Health, 2010.

34. The Federal Ministry of Health.

National strategic action plan (NSAP)

for prevention and control of non-communicable diseases in Ethiopia

2014–2016.

Addis Ababa, Ethiopia: Federal Democratic Republic of

Ethiopia Ministry of Health, 2014.

35. Ethiopia Ministry of Health.

Health Sector Transformation Plan

(HSTP) 2015/16–2019/20.

Addis Ababa, Ethiopia: The Federal

Democratic Republic of Ethiopia Ministry of Health, October 2015.

36. Ministry of Health.

Health Sector Transformation Plan II 2020/21–

2024/25

(Draft).

Addis Ababa: Federal Democratic Republic of

Ethiopia, 2020.

37. USAID. Health Care Financing Reform in Ethiopia: Improving Quality

and Equity.

Health Systems 20/20.

[Online] March 2012. https://www.

hfgproject.org/health-care-financing-reform-ethiopia-improving-quali-

ty-equity/.

38. World Health Organization. Health Topics. WHO, Regional Office for

Africa.

[Online] [Cited: 5 April 2019.]

https://www.afro.who.int/health-

topics/health-topics-ethiopia.

39. Hutubessy R, Chisholm D, Tan-Torres Edejer T and WHO-CHOICE.

Generalized cost-effectiveness analysis for national-level priority-setting

in the health sector.

Cost Eff Resour Alloc

2003;

1

: 8.

40. Tolla MT, Norheim OF, Memirie ST,

et al

. Prevention and treatment

of cardiovascular disease in Ethiopia: a costeffectiveness analysis.

Cost Eff Resour Alloc

2016;

14

(10): 1–14.

41. 41. World Health Organization. FCTC Implementation Database.

Ethiopia: parliament passing one of the strongest tobacco control

legislations in Africa. [Online] 2019.

https://untobaccocontrol.org/

impldb/ethiopia-parliament-passing-one-of-the-strongest-tobacco-

control-legislations-in-africa/.

42. Marquez PV. Ethiopia’s new tobacco control law: a step forward

that needs to be complemented by higher taxes!

Investing in Health.

[Online] February 15, 2019.

https://blogs.worldbank.org/health/ethi-

opia-s-new-tobacco-control-law-step-forward-needs-be-complement-

ed-higher-taxes.

43. Tarantino L, Laird K, Ottosson A,

et al

. Institutional roles and rela-

tionships governing the quality of health care: country experiences,

challenges, and lessons learned.

Bethesda, MD: Health Finance &

Governance Project, Abt Associates and USAID Applying Science

to Strengthen and Improve Systems Project, URC, 2016.

44. Lim SS, Gaziano TA, Gakidou E,

et al

. Prevention of cardiovascular

disease in high-risk individuals in low-income and middle-income

countries: health effects and costs.

Lancet

2007;

370

: 2054–2062.